Glibenclamide for the treatment of acute CNS injury. - Wikidata - awgldk - TriplyDB

Glibenclamide for the treatment of acute CNS injury.

Glibenclamide for the treatment of acute CNS injury.

http://www.wikidata.org/entity/Q37279993

about

Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?Investigational agents for treatment of traumatic brain injury Endothelin-1 Immunoreactivity and its Association with Intramedullary Hemorrhage and Myelomalacia in Naturally Occurring Disk Extrusion in Dogs Potential of glyburide to reduce intracerebral edema in brain metastases.Brain transient receptor potential channels and stroke.Sulfonylureas--a novel treatment to reduce tissue damage after acute spinal cord injury?Anthelminthic activity of glibenclamide on secondary cystic echinococcosis in mice.Effects of stevia on synaptic plasticity and NADPH oxidase level of CNS in conditions of metabolic disorders caused by fructose.Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β.

P2860

Q26751399-44EFF71F-C8A0-4CA3-8651-EACEE962DFA8 Q26827634-078224A4-8F39-4157-868A-FB862717E789 Q35611476-3ECE2D83-635A-4740-82A5-DE1E9D34E16C Q37391757-4DB16D84-E15A-4C2A-BFDE-04E32CFA0718 Q38189496-DA914E54-600B-4C68-A36C-2A309DA2C1FE Q38287205-EFC68FC9-2843-427F-A44E-1014515A7810 Q43105719-180183B1-3F6D-42E2-8DB0-69F7F5A58460 Q47105521-4F41E7FC-FC7D-4FE0-9C3D-6243B408AF2D Q47140886-8BEB280E-15A6-4A06-A5C9-BF42EB793DFF Q47963951-2838F01C-2761-430B-B2D8-BD7AE5A84903

P2860

Glibenclamide for the treatment of acute CNS injury.

http://www.wikidata.org/entity/Q37279993

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Glibenclamide for the treatment of acute CNS injury.

@en

Glibenclamide for the treatment of acute CNS injury.

@nl

type

label

Glibenclamide for the treatment of acute CNS injury.

@en

Glibenclamide for the treatment of acute CNS injury.

@nl

prefLabel

Glibenclamide for the treatment of acute CNS injury.

@en

Glibenclamide for the treatment of acute CNS injury.

@nl

P1433

Q37279993-3605EB56-EA06-4AE2-A3A6-28CD4BD1D2D4

P1476

Q37279993-495BA453-0A51-466C-BD13-DA4808C3F7E4

P2093

Q37279993-21048B4B-276D-4E45-9C76-2D0925F69554

Q37279993-2676241C-A045-490C-A0E0-358C8A467F64

Q37279993-2F205B84-FDA3-43AA-9FBC-4B3B49549108

Q37279993-57FEC53D-C107-4522-9202-A8444D4320A2

Q37279993-5C16B1C0-A7B0-48B6-B76D-D0637B09D59C

Q37279993-7352DE83-C096-45F5-948A-4F821F0BE98A

Q37279993-940D2CC1-D585-4BC6-9C2D-5FACE443CB43

P2860

Q37279993-027EC032-9D48-44F4-8F34-CD4116E0D260

Q37279993-0451D814-011C-418C-A03A-AC25D049D77B

Q37279993-0C1E2FDF-C221-4C99-91AA-E9A293CF5FC9

Q37279993-0C38E370-E706-4841-A0DA-7A660C82C278

Q37279993-0C898C8C-FED3-4818-BED4-C177835E4085

Q37279993-12621185-E241-411D-A815-A4C5034B45F2

Q37279993-1B2B7000-9ADE-40C7-A1B7-C714E5D52269

Q37279993-1ED16EC0-170E-42B2-97A2-B030FF4A4FA4

Q37279993-211B633D-1324-43F6-9426-D81FDC4C3C8E

Q37279993-218914BD-1B64-45C7-AC82-9545A83C277A

P304

Q37279993-57887882-6F63-4A21-984E-C064E7C0CCCC

P31

Q37279993-626F88FC-0A9A-40EA-A351-031D07CEF9F6

P356

Q37279993-F13340AE-6E2B-41BC-B064-D6A2F8924E40

P433

Q37279993-C0A48B2B-54C0-462D-BD6B-1EF9BF347300

P478

Q37279993-6E554ACD-A96C-4331-9601-65BCCC4D758C

P577

Q37279993-9FDB9774-B47D-435A-8513-DC8C9D4EF98E

P5875

Q37279993-11428EFA-4C1B-4E0C-98E2-EA7C0CF9FCD4

P698

Q37279993-9229134E-7AAB-459E-9591-C5CA6F323290

P932

Q37279993-D932CF5A-CD0B-494B-8BFE-F131742CF5BD

P356

P1433

Pharmaceuticals

P1476

Glibenclamide for the treatment of acute CNS injury.

@en

P2093

Adam Pampori

http://www.w3.org/2001/XMLSchema#string

Cigdem Tosun

http://www.w3.org/2001/XMLSchema#string

David B Kurland

http://www.w3.org/2001/XMLSchema#string

J Marc Simard

http://www.w3.org/2001/XMLSchema#string

Jason K Karimy

http://www.w3.org/2001/XMLSchema#string

Nicholas M Caffes

http://www.w3.org/2001/XMLSchema#string

Volodymyr Gerzanich

http://www.w3.org/2001/XMLSchema#string

P2860

Sulfonylurea receptor 1 in central nervous system injury: a focused review

Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke

Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke

Neuroprotective role of ATP-sensitive potassium channels in cerebral ischemia

Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?

ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats

Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage

Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage

P304

1287-1303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH6101287

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258921999

http://www.w3.org/2001/XMLSchema#string

P698

24275850

http://www.w3.org/2001/XMLSchema#string

P932

3817601

http://www.w3.org/2001/XMLSchema#string